FIELD: medicine; anaesthesiology and resuscitation.
SUBSTANCE: invention can be used to predict postoperative delirium in children during surgical correction of septal congenital heart defects under artificial circulation. The serum concentration of the combination of markers of brain damage is determined immediately after completion of cardiopulmonary bypass. When protein levels exceed S100β above 874.7 ng/ml, neuron-specific enolase above 35.79 ng/ml and glial fibrillary acidic protein above 0.1098 ng/ml, a high probability of postoperative delirium is predicted. The invention provides improved diagnostics of the presence of postoperative delirium and prophylaxis to prevent its occurrence. It also helps to take measures to improve the detection of delirium, especially its hypoactive form, in the form of increasing the frequency of testing the patient using the postoperative delirium rating scale.
EFFECT: possibility to make a decision on the initiation of cerebroprotective therapy.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF THE EARLY POSTOPERATIVE PERIOD COURSE ESTIMATION IN PATIENTS OPERATED FOR CHRONIC RHEUMATIC HEART DISEASE | 2017 |
|
RU2642600C1 |
METHOD FOR PREDICTING THE PROBABILITY OF FATAL OUTCOME IN 14-DAY PERIOD OF ACUTE ISCHEMIC STROKE OF THE BRAIN | 2020 |
|
RU2748685C1 |
METHOD OF EARLY PREDICTION OF POSTOPERATIVE COGNITIVE DYSFUNCTION IN IHD PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY | 2022 |
|
RU2795206C1 |
METHOD FOR PREDICTION OF COMORBID COURSE OF AFFECTIVE DISORDERS AND ALCOHOLISM BASED ON DETERMINATION OF BLOOD SERUM PROTEINS | 2021 |
|
RU2767699C1 |
METHOD FOR PREDICTING NEUROLOGICAL RECOVERY FROM THE 14TH TO THE 90TH DAYS OF ISCHEMIC STROKE OF THE BRAIN | 2021 |
|
RU2764355C1 |
METHOD FOR PREDICTION OF SEPSIS FOLLOWING CARDIOSURGICAL OPERATIONS PERFORMED IN CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION | 2019 |
|
RU2713930C1 |
METHOD FOR PREDICTION OF POSTOPERATIVE PERIOD IN ADULT PATIENTS WITH ACUTE HEART FAILURE AFTER OPEN HEART SURGERY THAT RECEIVE TREATMENT BY EXTRACORPORAL MEMBRANE OXYGENATION | 2016 |
|
RU2639096C1 |
NOVEL N-SULPHANILAMIDE DERIVATIVE OF PYRIMIDIN-4(1H)-ONE, HAVING CEREBROPROTECTIVE ACTIVITY FOR TREATING CHRONIC TRAUMATIC ENCEPHALOPATHY | 2019 |
|
RU2711613C1 |
METHOD FOR PREDICTION OF DEVELOPING COMPLICATED SYSTEMIC INFLAMMATION RESPONSE IN PATIENTS WITH SEPTIC ENDOCARDITIS | 2013 |
|
RU2520753C1 |
METHOD FOR PREDICTING COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER CARDIAC SURGERIES WITH ARTIFICIAL CIRCULATION | 2017 |
|
RU2680602C1 |
Authors
Dates
2024-03-19—Published
2023-05-22—Filed